News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Nova Mentis Begins Recruitment in First-of-its-Kind Health Canada Psilocybin Trial
Nova Mentis Life Science
Wellbeing Subsidiary KGK Science Begins Recruitment in First-of-its-Kind Health Canada Approved Psilocybin Trial
Wellbeing Digital Sciences
Awakn Life Sciences Signs Collaboration Agreement with University of Exeter for Upcoming Phase III Trial
Awakn Life Sciences
MindMed Collaborators Announce Positive Topline Data from Phase 2 Trial of Lysergide (LSD) in Major Depressive Disorder (MDD)
Mind Medicine (MindMed)
Nova Mentis Receives Institutional Review Board Approval to Commence Psilocybin Clinical Trial
Nova Mentis Life Science
Tryp Therapeutics Announces Private Placement of Secured Convertible Debentures for Gross Proceeds of a Minimum of AUD$2,000,000
Tryp Therapeutics
Algernon NeuroScience Announces Successful Dosing of 2nd Cohort in Phase 1 DMT Clinical Study
Algernon Pharmaceuticals
Tryp Therapeutics Completes Psychotherapy Training for Planned Phase 2a Clinical Trial at Massachusetts General Hospital
Tryp Therapeutics
Clearmind Medicine Announces Pricing of US$3.5 Million Public Offering
Clearmind Medicine
Algernon NeuroScience Announces U.S. SEC Qualification of Regulation A+ Tier II Offering to Raise up to USD $10M
Algernon Pharmaceuticals
Revive Therapeutics Advances MDMA Transdermal Patch Development with Purchase of MDMA Supply from PharmAla Biotech
Revive Therapeutics
Psyence Group Announces Closing of Fourth Tranche of Private Placement and Conversion of Convertible Debt Note
Psyence Group
Algernon Pharmaceuticals Announces Launch of Rights Offering
Algernon Pharmaceuticals
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.